Emergence of anthrax edema toxin as a master manipulator of macrophage and B cell functions

Toxins

Volumn 2, Issue 7, 2010, Pages 1881-1897

  Gnade, Bryan T ^a   Moen, Scott T ^a   Chopra, Ashok K ^a   Peterson, Johnny W ^a   Yeager, Linsey A ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Anthrax; B cell; CAMP signaling; Edema toxin; Macrophage

Indexed keywords

ANTHRAX TOXIN; CELL SURFACE MARKER; CYCLIC AMP; EDEMA TOXIN; UNCLASSIFIED DRUG;

ANTHRAX; B LYMPHOCYTE; CELL MOTILITY; CYTOKINE RESPONSE; CYTOTOXICITY; ENZYME ACTIVITY; GENE CONTROL; HUMAN; INNATE IMMUNITY; INTRACELLULAR SIGNALING; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TARGET CELL; TOXIN ANALYSIS;

ANIMALS; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL TOXINS; HUMANS; MACROPHAGES;

BACILLUS ANTHRACIS;

EID: 79952075308     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins2071881     Document Type: Review

References (65)

1. Scobie, H.; Rainey, G.; Bradley, K.; Young, J. Human capillary morphogenesis protein2 functions as an anthrax toxin receptor. Proc. Natl. Acad. Sci. USA 2003, 100, 5170-5174.
2. Bradley, K.; Mogridge, J.; Mourez, M.; Collier, R.; Young, J. Identification of the cellular receptor for anthrax toxin. Nature 2001, 414, 225-229.
3. Cataldi, A.; Labruyere, E.; Mock, M. Construction and characterization of a protective antigen- deficient Bacillus anthracis strain. Mol. Microbiol. 1990, 4, 1111-1117.
4. Pezard, C.; Duflot, E.; Mock, M. Construction of Bacillus anthracis mutant strains producing a single toxin component. J. Gen. Microbiol. 1993, 139, 2459-2463.
5. Heninger, S.; Drysdale, M.; Lovchik, J.; Hutt, J.; Lipscomb, M.F.; Koehler, T.M.; Lyons, C.R. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax. Infect. Immun. 2006, 74, 6067-6074.
6. Welkos, S.L.; Vietri, N.J.; Gibbs, P.H. Non-toxigenic derivatives of the Ames strain of Bacillus anthracis are fully virulent for mice: role of plasmid pX02 and chromosome in strain-dependent virulence. Microb. Pathog. 1993, 14, 381-388.
7. Brachman, P.; Friedlander, A. Anthrax. In Vaccines, 3rd ed.; Plotkin, S., Orenstein, W., Eds.; WB Saunders Co: Philadelphia, PA, USA, 1999; pp. 629-637.
8. Lebowich, R.J.; McKillip, B.G.; Conboy, J.R. Cutaneous anthrax: a pathological study with clinical correlation. Am. J. Clin. Pathol. 1943, 13, 505-515.
9. Beatty, M.E.; Ashford, D.A.; Griffin, P.M.; Tauxe, R.V.; Sobel, J. Gastrointestinal anthrax: Review of the literature. Arch. Intern. Med. 2003, 163, 2527-2531.
10. Glomski, I.; Piris-Gimenez, A.; Huerre, M.; Mock, M.; Goossens, P. Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathog. 2007, 3, e76.
11. Chakrabarty, K.; Wu, W.; Booth, J.; Duggan, E.; Coggeshall, K.; Metcalf, J. Bacillus anthracis spores stimulate cytokine and chemokine innate immune responses in human alveolar macrophages through multiple mitogen-activated protein kinase pathways. Infect. Immun. 2006, 74, 4430-4438.
12. Cleret, A.; Quesnel-Hellmann, A.; Vallon-Eberhard, A.; Verrier, B.; Jung, S.; Vidal, D.; Mathieu, J.; Tournier, J. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol. 2007, 178, 7994-8001.
13. Vitale, G.; Bernardi, L.; Napolitano, G.; Mock, M.; Montecucco, C. Susceptibility of mitogen- activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 2000, 352, 739-745.
14. Kirby, J. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 2004, 72, 430-439.
15. Friedlander, A.; Bhatnagar, R.; Leppla, S.; Johnson, L.; Singh, Y. Characterization of macrophage sensitivity and resistance to anthrax lethal toxin. Infect. Immun. 1993, 61, 245-252.
16. Lin, C.; Kao, Y.; Liu, W.; Huang, H.; Chen, K.; Wang, T.; Lin, H. Cytotoxic effects of anthrax lethal toxin on macrophage-like cell lines J774A.1. Curr. Microbiol. 1996, 33, 224-227.
17. Alileche, A.; Serfass, E.; Muehlbauer, S.; Porcelli, S.; Brojatsch, J. Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathog. 2005, 1, 150-158.
18. Popov, S.; Villasmil, R.; Bernardi, J.; Grene, E.; Cardwell, J.; Wu, A.; Alibek, D.; Bailey, C.; Alibek, K. Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 2002, 293, 349-355.
19. Molin, F.D.; Fasanella, A.; Simonato, M.; Garofolo, G.; Montecucco, C.; Tonello, F. Ratio of lethal and edema factors in rabbit systemic anthrax. Toxicon 2008, 52, 824-828.
20. Leppla, S. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc. Natl. Acad. Sci. USA 1982, 79, 3162-3166.
21. Drum C.L.; Yan, S.Z.; Bard, J.; Shen, Y.Q.; Lu, D.; Soelaiman, S.; Grabarek, Z.; Bohm, A.; Tang, W.J. Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 2002, 415, 396-402.
22. Leppla, S. Bacillus anthracis calmodulin-dependent adenylate cyclase: chemical and enzymatic properties and interactions with eukaryotic cells. In Advances in Cyclic Nucleotide and Protein Phosphorylation Research; Greengard, P., Robinson, B.A., Eds.; Raven Press: New York, NY, USA, 1984; pp. 189-198.
23. Tang, W.; Krupinski, J.; Gilman, A. Expression and characterization of calmodulin-activated (type 1) adenylyl cyclases. J. Biol. Chem. 1991, 266, 8595-8603.
24. Ahuja, N.; Kumar, P.; Bhatnagar, R. The adenylate cyclase toxins. Crit. Rev. Microbiol. 2004, 30, 187-196.
25. Crawford, M.A.; Aylott, C.V.; Bourdeau, R.W.; Bokoch,G.M. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J. Immunol. 2006, 176, 7557-7565.
26. Hong, J.; Doebele, R.; Lingen, M.; Quilliam, L.; Tang, W.; Rosner, M. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J. Biol. Chem. 2007, 282, 19781-19787.
27. Comer, J.E.; Chopra, A.K.; Peterson, J.W.; Konig, R. Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect. Immun. 2005, 73, 8275-8281.
28. Rossi Paccani, S.; Tonello, F.; Ghittoni, R.; Natale, M.; Muraro, L.; d'elios, M.M.; Tang, W.J.; Montecucco, C.; Baldari, C.T. Anthrax toxins suppress T-lymphocyte activation by disrupting antigen receptor signaling. J. Exp. Med. 2005, 201, 325-331.
29. Tournier, J.N.; Quesnel-Hellmann, A.; Mathieu, J.; Montecucco, C.; Tang, W.J.; Mock, M.; Vidal, D.R.; Goossens, P.L. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J. Immunol. 2005, 174, 4934-4941.
30. Szarowicz, S.E.; During, R.L.; Li, W.; Quinn, C.P.; Tang, W.J.; Southwick, F.S. Bacillus anthracis edema toxin impairs neutrophil actin-based motility. Infect. Immun. 2009, 77, 2455-2464.
31. Puhar, A.; Molin, F.D.; Horvath, S.; Ladants, D.; Montecucco, C. Anthrax edema toxin modulates PKA- and CREB-dependent signaling in two phases. PLoS One 2008, 3, e3564.
32. Paccani, S.R.; Tonello, F.; Patrussi, L.; Capitani, N.; Simonato, M.; Montecucco, C.; Baldari, C. Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signaling. Cell. Microbiol. 2007, 9, 924-929.
33. Kim, C.; Wilcox-Adelman, S; Sano, Y.; Tang, W.; Collier, R.J.; Park, J. Anti-inflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus. Proc. Natl. Acad. Sci. USA 2008, 105, 6150-6155.
34. Maldonado-Arocho, F.J.; Fulcher, J.A.; Lee, B.; Bradley, K.A. Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol. Microbiol. 2006, 61, 324-337.
35. Xu, L.; Frucht, D. Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses. Int. J. Biochem. Cell. Biol. 2007, 39, 20-24.
36. Turk, B.E. Manipulation of host signaling pathways by anthrax toxins. Biochem. J. 2007, 402, 405-417.
37. Cote, C.K.; Rea, K.M.; Norris, S.L.; van Rooijen, N.; Welkos, S.L. The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. Microb. Pathog. 2004, 37, 169-175.
38. Cote, C.; Van Rooijen, N.; Welkos, S. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun. 2006, 74, 469-480.
39. Cote, C.; DiMezzo, T.; Banks, D.; France, B.; Bradley, K.; Welkos, S. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microb. Infect. 2008, 10, 613-619.
40. Comer, J.; Galindo, C.; Zhang, F.; Wenglikowski, A.; Bush, K.; Garner, H.; Peterson, J.; Chopra, A. Murine macrophage transcriptional and functional responses to Bacillus anthracis edema toxin. Microb. Pathog. 2006, 41, 96-110.
41. Banks, D.; Barnajian, B.; Maldonado-Arocho, F.; Sanchez, A.; Bradley, K. Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge. Cell. Microbiol. 2005, 7, 1173-1185.
42. Park, J.M.; Greten, F.R.; Wong, A.; Westrick, R.J.; Arthur, J.S.C.; Otsu, K.; Hoffmann, A.; Montminy, M.; Karin, M. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaβ as key regulators. Immunity 2005, 23, 319-329.
43. de Rooij, J.; Zwartkruis, F.J.; Verheijen, M.H.; Cool, R.H.; Nijman, S.M.; Wittinghofer, A.; Bos, J.L. Epac is a Rap1 guanine-nucleotide exchange factor directly activated by cyclic AMP. Nature 1998, 396, 474-477.
44. Kawasaki, H.; Springett, G.M.; Mochizuki, N.; Toki, S.; Nakaya, M.; Matsuda, M.; Housman, D.E.; Graybiel, A.M. A family of cAMP binding proteins that directly activate Rap1. Science 1998, 282, 2275-2279.
45. Yeager, L.A.; Chopra, A.K.; Peterson, J.W. Bacillus anthracis edema toxin suppresses human macrophage phagocytosis and cytoskeletal remodeling via the Protein Kinase A and Exchange Protein Activated by cyclic AMP pathways. Infect. Immun. 2009, 77, 2530-2543.
46. Kumar, P.; Ahuja, N.; Bhatnagar, R. Anthrax edema toxin requires influx of calcium for inducing cyclic AMP toxicity in target cells. Infect. Immun. 2002, 70, 4997-5007.
47. Voth, D.; Hamm, E.; Nguyen, L.; Tucker, A.; Salles, I.; Ortiz-Leduc, O.; Ballard, J. Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell. Microbiol. 2005, 7, 1139-1149.
48. Firoved, A.M.; Miller, G.F.; Moayeri, M.; Kakkar, R.; Shen, Y.; Wiggins, J.F.; McNally, E.M.; Tang, W.J.; Leppla, S.H. Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 2005, 167, 1309-1320.
49. O'Brien, J.; Friedlander, A.; Dreier, T.; Ezzell, J.; Leppla, S. Effects of anthrax toxin components on human neutrophils. Infect. Immun. 1985, 47, 306-310.
50. Shen, Y.; Zhukovskaya, N.; Zimmers, M.; Soelaiman, S.; Bergson, P., Wang, C., Gibbs, C., Tang, W. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc. Natl. Acad. Sci. USA 2004, 101, 3242-3247.
51. Bailly, S.; Ferrua, B.; Fay, M.; Gougerot, P.M. Differential regulation of IL-6, IL-1 alpha, IL-1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP. Infect. Immun. 1994, 62, 4432-4439.
52. Hart, P.H.; Whitty, G.A.; Piccoli, S.; Hamilton, J.A. Control by IFN-γ and PGE2 of TNFα and IL-1 production by human monocytes. Immunology 1989, 66, 376-383.
53. Hoover, D.; Firedlander, A.; Rogers, L.; Yoon, I. Anthrax edema toxin differentially regulates LPS-induced monocyte production of tumor necrosis factor alpha and interleukin-6 by increasing intracellular cAMP. Infect. Immun. 1994, 62, 4432-4439.
54. Bermudez, L.E.; Young, L.S. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 1988, 140, 3006-3013.
55. Cross, A.S.; Sadoff, J.C.; Kelly, N.; Bernton, E.; Gemski, P. Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J. Exp. Med. 1989, 169, 2021-2027.
56. Pezard, C.; Berche, P.; Mock, M. Contribution of individual toxin components to virulence of Bacillus anthracis. Infect. Immun. 1991, 59, 3472-3477.
57. Fang, H.; Xu, L.; Chen, T.Y.; Cyr, J.M.; Frucht, D.M. Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J. Immunol. 2006, 176, 6155-6161.
58. Lomo, J.; Blomhoff, H.K.; Beiske, K.; Stokke, T.; Smeland, E.B. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J. Immunol. 1995, 154, 1634-1643.
59. Okada, T.; Cyster, J.G. B cell migration and interactions in the early phase of antibody responses. Curr. Opin. Immunol. 2006, 18, 278-285.
60. Reif, K.; Ekland, E.H.; Ohl, L.; Nakano, H.; Lipp, M.; Forster, R.; Cyster, J.G. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002, 416, 94-99.
61. Okada, T.; Ngo, V.N.; Ekland, E.H.; Forster, R.; Lipp, M.; Littman, D.R. Cyster, J.G. Chemokine requirements for B cell entry to lymph nodes and Peyer's patches. J. Exp. Med. 2002, 196, 65-75.
62. Krzysiek, R.; Lefevre, E.A.; Zou, W.; Foussat, A.; Bernard, J.; Portier, A.; Galanaud, P.; Richard, Y. Antigen receptor engagement selectively induces macrophage inflammatory protein-1 alpha (MIP-1 alpha) and MIP-1 beta chemokine production in human B cells. J. Immunol. 1999, 162, 4455-4463.
63. Zhang, Y.; Lin, J.X.; Vilcek, J. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J. Biol. Chem. 1988, 263, 6177-6182.
64. Orlikowsky, T.W.; Dannecker, G.E.; Spring, B.; Eichner, M.; Hoffmann, M.K.; Poets, C.F. Effect of dexamethasone on B7 regulation and T cell activation in neonates and adults. Pediatr. Res. 2005, 57, 656-661.
65. Wortis, H.H.; Teutsch, M.; Higer, M.; Zheng, J.; Parker, D.C. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B- cell phenotypes. Proc. Natl. Acad. Sci. USA 1995, 92, 3348-3352.